Search Within

Meira Yisraeli Salman

Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Adult Leukemia (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. GME, Medicine (6)
  6. Graduate Medical Education (6)

More Groups

People
  1. Eytan Stein (7)
  2. Ioannis Kalogirou Valtis (6)
  3. Kuo-Kai Chin (6)
  4. Leora Boussi (6)
  5. Christopher Famulare (5)
  6. Andriy Derkach (4)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
Publications
  1. Blood (2)
  2. Blood Advances (1)
  3. Blood Neoplasia (1)
  4. Cancer (1)
  5. Haematologica (1)
  6. JAMA Oncology (1)
Publishers
  1. American Society of Hematology (3)
  2. American Medical Association (1)
  3. Elsevier Inc. (1)
  4. Ferrata Storti Foundation (1)
  5. Wiley Blackwell (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs
    Journal Article

    Burton, H.; Boussi, L.; Nemirovsky, D.; Derkach, A.; Ciervo, J.; Famulare, C.; Chin, K. K.; Valtis, Y.; Yisraeli Salman, M.; Patel, K.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction
    Journal Article

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Barriers to chimeric antigen receptor T-cell therapy
    Research Letter

    Valtis, Y. K.; Chin, K. K.; Nemirovsky, D.; Devlin, S. M.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia
    Journal Article

    Chin, K. K.; Valtis, Y.; Derkach, A.; Yisraeli Salman, M.; Boussi, L.; Ciervo, J.; Geyer, M. B.; Park, J. H.; Tallman, M. S.; Glass, J. L.; more...
    Blood Neoplasia (2024)

    Fulltext@MSK | Save
  • Barriers to immune effector cell therapy: Rapid disease progression, concern for toxicity, and lack of appropriate trials drive non-receipt after referral at a large academic center
    Meeting Abstract

    Valtis, Y. K.; Chin, K. K.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; Brooklyn, C.; Goldstein, T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patients with AML and an IDH2-R172 mutation exhibit a unique response to intensive induction chemotherapy, suggesting futility of mid-cycle bone marrow biopsy and caution when considering re-induction
    Meeting Abstract

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Revumenib for patients with acute leukemia: A new tool for differentiation therapy
    Review

    Yisraeli Salman, M.; Stein, E. M.
    Haematologica (2024)

    Fulltext@MSK | Save